rilutek
sanofi winthrop industrie - riluzole - amyotrofická laterálna skleróza - Ďalšie lieky na nervový systém - rilutek je indikovaný na predĺženie života alebo času na mechanickú ventiláciu u pacientov s amyotrofickou laterálnou sklerózou (als). klinické štúdie preukázali, že rilutek sa predlžuje prežitie pre pacientov s als. prežitie bolo definované ako pacienti, ktorí boli nažive, nie intubated pre mechanické vetranie a tracheotomy-zadarmo. neexistuje žiaden dôkaz, že rilutek pôsobí terapeutický vplyv na motorické funkcie, funkciu pľúc, fasciculations, svalovú silu a motorových príznaky. rilutek nebola ukázali byť účinné v neskorých fázach als. bezpečnosti a účinnosti rilutek už boli len študoval v als. preto, rilutek by sa nemali používať u pacientov s akoukoľvek inou formou motor-neurone ochorenia.
bylvay
albireo - odevixibat - cholestasis, intrahepatic - liečba žlčou a pečeňou - bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (pfic) in patients aged 6 months or older (see sections 4. 4 a 5.
gél vaginálny gynella natal ferti gel
velit biopharma s.r.l. piazza cavour, n. 3 201 21 milano taliansko -
Čapíky vaginálne gynella flora
velit biopharma s.r.l. piazza cavour, n. 3 201 21 milano taliansko -
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcíny - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. použitie tejto vakcíny by mali byť v súlade s oficiálne odporúčania.
Čapíky vaginálne gynella balance
velit biopharma s.r.l. piazza cavour, n. 3 201 21 milano taliansko -
teriflunomide msn 14 mg filmom obalené tablety
msn labs europe limited, malta - teriflunomid - 59 - immunopraeparata
budenofalk 9 mg gastrorezistentný granulát
dr. falk pharma gmbh, nemecko - budezonid - 56 - hormona (lieČiva s hormonÁlnou aktivitou)
cefotaxim eberth 0,5 g
dr. friedrich eberth arzneimittel gmbh, nemecko - cefotaxím - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
cefotaxim eberth 1 g
dr. friedrich eberth arzneimittel gmbh, nemecko - cefotaxím - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)